EXPE
96
-3
AVY
53
2
LEN
52
2
NOC
40
-10
HUM
48
2
LOW
58
2
SHW
70
2
KHC
17
4
CHRW
67
3
SYY
47
-2
SLB
56
-3
GS
75
-4
EMN
50
-2
STX
52
-4
DG
12
2
TXT
62
2
SE
60
-5
TXN
49
-6
NWS
79
-4
NWSA
71
-2
EXPE
96
-3
AVY
53
2
LEN
52
2
NOC
40
-10
HUM
48
2
LOW
58
2
SHW
70
2
KHC
17
4
CHRW
67
3
SYY
47
-2
SLB
56
-3
GS
75
-4
EMN
50
-2
STX
52
-4
DG
12
2
TXT
62
2
SE
60
-5
TXN
49
-6
NWS
79
-4
NWSA
71
-2
Financhill
Back

Haemonetics Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Buy
86

HAE
Haemonetics

Last Price:
90.82
Seasonality Move:
4.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Haemonetics Price Quote

$90.82
-0.96 (-1.05%)
(Updated: November 14, 2024 at 5:55 PM ET)

Haemonetics Key Stats

Buy
86
Haemonetics (HAE) is a Buy
Day range:
$91.45 - $93.97
52-week range:
$70.25 - $97.97
Dividend yield:
0%
P/E ratio:
40.78
P/S ratio:
3.53
P/B ratio:
5.34%
Volume:
773.2K
Avg. volume:
619.8K
1-year change:
5.9%
Market cap:
$4.7B
Revenue:
$1.3B
EPS:
$2.41

How Much Does Haemonetics Make?

  • How Much Are Haemonetics's Sales Annually?
    HAE Revenues are $1.3B
  • How Much Profit Does Haemonetics's Make A Year?
    HAE net income is $117.6M

Is Haemonetics Growing As A Company?

  • What Is Haemonetics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.09%
  • What Is Haemonetics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.38%

Haemonetics Stock Price Performance

  • Did Haemonetics Stock Go Up Last Month?
    Haemonetics share price went up by 22.42% last month
  • Did HAE's Share Price Rise Over The Last Year?
    HAE share price rose by 5.9% over the past 1 year

What Is Haemonetics 52-Week High & Low?

  • What Is Haemonetics’s 52-Week High Share Price?
    Haemonetics has traded as high as $97.97 over the past 52 weeks
  • What Is Haemonetics’s 52-Week Low Share Price?
    Haemonetics has traded as low as $70.25 over the past 52 weeks

Haemonetics Price To Free Cash Flow

Is It Risky To Buy Haemonetics?

  • How Much Debt Does Haemonetics Have?
    Total long term debt quarterly is $1.2B
  • How Much Cash Does Haemonetics Have?
    Cash and short term investments quarterly total is $299.3M
  • What Is Haemonetics’s Book Value Per Share?
    Book value per share is 17.44

Is Haemonetics Cash Flow Positive?

  • What Is HAE Cash Flow From Operations?
    Cash flow from operations (TTM) is $84.9M
  • What Is Haemonetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $304.8M
  • What Is Haemonetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$444.6M

Haemonetics Return On Invested Capital

  • Is Management Doing A Good Job?
    HAE return on invested capital is 6.54%
  • What Is Haemonetics Return On Assets?
    ROA measures how assets are converting to revenues and is 5.4%
  • What Is HAE Return On Equity?
    ROE is a measure of profitability and is 13.51%

Haemonetics Earnings Date & Stock Price

  • What Is Haemonetics's Stock Price Today?
    A single share of HAE can be purchased today for 91.78
  • What Is Haemonetics’s Stock Symbol?
    Haemonetics trades on the nyse under the ticker symbol: HAE
  • When Is Haemonetics’s Next Earnings Date?
    The next quarterly earnings date for Haemonetics is scheduled on February 7, 2025
  • When Is HAE's next ex-dividend date?
    Haemonetics's next ex-dividend date is November 15, 2024
  • How To Buy Haemonetics Stock?
    You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Haemonetics Competitors

  • Who Are Haemonetics's Competitors?
    Below is a list of companies who compete with Haemonetics or are related in some way:
    • Baxter International Inc (BAX)
    • Becton Dickinson & Co (BDX)
    • Boston Scientific Corp (BSX)
    • Globus Medical Inc (GMED)
    • Insulet Corp (PODD)

Haemonetics Dividend Yield

Haemonetics Analyst Estimates

YoY Growth Past Surprise
EPS: 37.5% 4.39%
Revenue: 8.59% 0.86%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 110.80
Upside from Last Price: 20.72%

Major Shareholders

  • How many HAE shares are owned by institutional investors?
    93.1M HAE shares are owned by institutional investors
  • How many HAE shares are owned by insiders?
    1.4M HAE shares are owned by insiders